The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.

• 主要な著者: Pilar eSánchez-Blázquez (著者), María eRodriguez-Muñoz (著者), Javier eGarzon (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2014-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

The endocannabinoid system is widespread throughout the central nervous system and its type 1 receptor (CB1) plays a crucial role in preventing the neurotoxicity caused by activation of glutamate N-methyl-D-aspartate receptors (NMDARs). Indeed, it is the activity of NMDARs themselves that provides t...